Heartbeam logo
BEATHeartbeam
Trade BEAT now
Heartbeam primary media

About Heartbeam

Heartbeam (NASDAQ:BEAT) is a pioneering company focused on revolutionizing the management of heart disease through its innovative technology. Specializing in the development of advanced electrocardiogram (ECG) solutions, Heartbeam aims to make significant strides in detecting and monitoring heart conditions in a more accurate and efficient manner. Their projects are geared towards leveraging telemedicine and mobile health applications, aiming to provide patients and healthcare providers with critical, real-time cardiac data. Heartbeam's objective is centered around improving patient outcomes and reducing healthcare costs by facilitating early detection of heart issues, thus paving the way for prompt and effective treatment. With its commitment to innovation, Heartbeam is dedicated to leading the charge in transforming cardiac care for people around the globe.

What is BEAT known for?

Snapshot

Public US
Ownership
2015
Year founded
15
Employees
Santa Clara, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Santa Clara, US

Produtos e/ou serviços de Heartbeam

  • A breakthrough ECG software technology designed to precisely detect heart attacks using a combination of standard and novel ECG leads.
  • A portable, credit card-sized device enabling real-time, 12-lead ECG recording and heart attack detection.
  • A cloud-based platform providing secure, real-time analysis and reporting of ECG data for prompt diagnosis.
  • A telemedicine service facilitating remote cardiac monitoring and consultations, improving access to cardiac care.
  • An advanced algorithm for detecting subtle signs of ischemia in ECG signals, enhancing early diagnosis.
  • A research partnership focused on integrating AI with ECG technology to predict and prevent cardiac events.

equipe executiva do Heartbeam

  • Mr. Richard M. FerrariExecutive Chairman
  • Mr. Robert P. EnoCEO, Chief Business Officer & Director
  • Dr. Branislav Vajdic Ph.D.Founder, President & Director
  • Mr. Timothy CruickshankChief Financial Officer
  • Mr. Kenneth PersenChief System Development Officer
  • Dr. Peter J. Fitzgerald FACC, M.D., Ph.D.Member of Scientific Advisory Board & Chief Medical Advisor
  • Ms. Richa GujaratiSenior Vice President of Product
  • Dr. Lance Myers Ph.D.Chief Artificial Intelligence Scientist
  • Mr. Bryan HumbargerChief Commercial Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.